Pre-treatment gut microbiome and salivary metabolome signatures associate with chemotherapy-induced cognitive decline in women with breast cancer: A prospective pilot study.
Saved in:
| Title: | Pre-treatment gut microbiome and salivary metabolome signatures associate with chemotherapy-induced cognitive decline in women with breast cancer: A prospective pilot study. |
|---|---|
| Authors: | Cross CB; School of Pharmacy and Biomedical Science, College of Health, Adelaide University, South Australia, Australia; Supportive Oncology Research Group, Precision Medicine (Cancer), South Australian Health and Medical Research Institute (SAHMRI), University of Adelaide, South Australia, Australia. Electronic address: courtney.cross@adelaide.edu.au., Bowen JM; School of Pharmacy and Biomedical Science, College of Health, Adelaide University, South Australia, Australia., Leifert WR; CSIRO Health & Biosecurity, Nutrition and Health Program, Cell & Molecular Health Group, Adelaide, South Australia, Australia; School of Biological Sciences, University of Adelaide, South Australia, Australia., Beale DJ; CSIRO Environment, Industry Environments Program, Health Communities Group, Dutton Park, Queensland, Australia., Francois M; CSIRO Health & Biosecurity, Nutrition and Health Program, Cell & Molecular Health Group, Adelaide, South Australia, Australia., Joshi R; Medical Oncology, Lyell McEwin Hospital, Adelaide, South Australia, Australia; School of Medicine, College of Health, Adelaide University, South Australia, Australia., Fosh BG; School of Medicine, College of Health, Adelaide University, South Australia, Australia; Adelaide Plastic Surgery, South Australia, Australia., Coller JK; School of Pharmacy and Biomedical Science, College of Health, Adelaide University, South Australia, Australia., Tuke J; School Mathematical Sciences, Adelaide University, South Australia, Australia., Bareham M; Health Performance Council, Government of South Australia, South Australia, Australia., Cosier DJ; School of Medicine, Indigenous and Health Sciences, University of Wollongong, New South Wales, Australia., To LH; School of Pharmacy and Biomedical Science, College of Health, Adelaide University, South Australia, Australia; Supportive Oncology Research Group, Precision Medicine (Cancer), South Australian Health and Medical Research Institute (SAHMRI), University of Adelaide, South Australia, Australia., Ryan FJ; Computational Multi-Omics Group, College of Medicine and Public Health, Flinders University, Bedford Park, South Australia, Australia., Wardill HR; School of Pharmacy and Biomedical Science, College of Health, Adelaide University, South Australia, Australia; Supportive Oncology Research Group, Precision Medicine (Cancer), South Australian Health and Medical Research Institute (SAHMRI), University of Adelaide, South Australia, Australia. |
| Source: | Cancer letters [Cancer Lett] 2026 Mar 01; Vol. 640, pp. 218234. Date of Electronic Publication: 2026 Jan 07. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7980 (Electronic) Linking ISSN: 03043835 NLM ISO Abbreviation: Cancer Lett Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
